Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Ivana, Carey"'
Autor:
Milan J. Sonneveld, Shao-Ming Chiu, Jun Yong Park, Sylvia M. Brakenhoff, Apichat Kaewdech, Wai-Kay Seto, Yasuhito Tanaka, Ivana Carey, Margarita Papatheodoridi, Piero Colombatto, Florian van Bömmel, Thomas Berg, Fabien Zoulim, Sang Hoon Ahn, George N. Dalekos, Nicole S. Erler, Maurizia Brunetto, Heiner Wedemeyer, Markus Cornberg, Man-Fung Yuen, Kosh Agarwal, Andre Boonstra, Maria Buti, Teerha Piratvisuth, George Papatheodoridis, Chien-Hung Chen, Benjamin Maasoumy
Publikováno v:
JHEP Reports, Vol 5, Iss 8, Pp 100790- (2023)
Background & Aims: Pretreatment predictors of finite nucleo(s)tide analogue (NUC) therapy remain elusive. We studied the association between pretreatment HBV DNA levels and outcomes after therapy cessation. Methods: Patients with chronic hepatitis B
Externí odkaz:
https://doaj.org/article/ed567dc91f3c4d328c67f9acb5bbb743
Autor:
Ivana Carey, Moigboi Christiana, McLeod Marie‐Ange, Bowyer Teresa, Guerra Veloz Maria, Geoff Dusheiko, Kosh Agarwal
Publikováno v:
Journal of Viral Hepatitis. 29:1079-1088
Universal hepatitis C screening in pregnancy is not recommended by NICE due to a lack of effective interventions to prevent mother to child transmission (MTCT) and is only offered to pregnant women at increased risk of infection (intra-venous drug us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8791f4e128ff9bbdf531f075066f6a9
https://doi.org/10.1111/jvh.13752
https://doi.org/10.1111/jvh.13752
Autor:
Kosh Agarwal, James Lok, Ivana Carey, Yatin Shivkar, Michael Biermer, Thomas Berg, Isabelle Lonjon-Domanec
Publikováno v:
Journal of Hepatology. 77:245-248
Nucleoside analogues are the mainstay of treatment for patients with chronic HBV infection but have no direct effect on covalently closed circular DNA. Long-term HBV viral suppression is now routine, but the desirable endpoint of functional cure is r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2be102997770e1e7dab789b29c1a2bf
https://doi.org/10.1016/j.jhep.2022.03.006
https://doi.org/10.1016/j.jhep.2022.03.006
Autor:
Markus Cornberg, Christoph Höner zu Siederdissen, George N. Dalekos, Fabien Zoulim, Milan J. Sonneveld, Wai-Kay Seto, Nicole S. Erler, Heiner Wedemeyer, Thomas Berg, Ivana Carey, Jun Yong Park, Kosh Agarwal, Yasuhito Tanaka, Sang Hoon Ahn, Benjamin Maasoumy, Apichat Kaewdech, Teerha Piratvisuth, Maria Buti, Man-Fung Yuen, George V. Papatheodoridis, Andre Boonstra, Margarita Papatheodoridi, Florian van Bömmel
Publikováno v:
Clinical Gastroenterology and Hepatology, 20(4), e784-e793. W.B. Saunders
Background & Aims: Predictors of successful nucleo(s)tide analogue (NA) therapy withdrawal remain elusive. We studied the relationship between end-of-treatment levels of hepatitis B core-related antigen (HBcrAg) and hepatitis B surface antigen (HBsAg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6d5a1a431840ac4a4ad82b2c6ed8db9
http://www.scopus.com/inward/record.url?scp=85104274872&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85104274872&partnerID=8YFLogxK
Autor:
Abhinav Kumar, Milan J. Sonneveld, Shao-Ming Chiu, Jun Y. Park, Sylvia M. Brakenhoff, Apichat Kaewdech, Wai-Kay Seto, Yasuhito Tanaka, Ivana Carey, Margarita Papatheodoridi, Florian van Bommel, Thomas Berg, Fabien Zoulim, Sang H. Ahn, George N. Dalekos, Nicole S. Erler, Christoph H. zu Siederdissen, Heiner Wedemeyer, Markus Cornberg, Man-Fung Yuen, Kosh Agarwal, Andre Boonstra, Maria Buti, Teerha Piratvisuth, George Papatheodoridis, Chien-Hung Chen, Benjamin Maasoumy
Publikováno v:
Journal of Clinical and Experimental Hepatology. 12:1385-1387
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::455238681aa4d057a8478a7059bbb790
https://doi.org/10.1016/j.jceh.2022.04.007
https://doi.org/10.1016/j.jceh.2022.04.007
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 11 (2018)
Tenofovir alafenamide (TAF), a novel prodrug of tenofovir was developed to deliver enhanced antiviral potency and reduced systemic toxicities by more efficient intracellular delivery of the active metabolite tenofovir disphosphate than tenofovir diso
Externí odkaz:
https://doaj.org/article/7c1cd6325ce448bcb857c4e2deefc5d6
Autor:
Khin Han, Ngozi Adibe, Saima Ajaz, Almuthana Mohamed, Maria Guerra-Veloz, James Lok, Ivana Carey, Kosh Agarwal
Publikováno v:
Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49a6b4870bf26971de4d113516532565
https://doi.org/10.1136/gutjnl-2022-basl.105
https://doi.org/10.1136/gutjnl-2022-basl.105
Autor:
Almuthana Mohamed, Lindsay Greenland, Maria Guerra Veloz, Racquel Beckford, Deepak Joshi, Varuna Aluvihare, Abid Suddle, Michael Heneghan, Ivana Carey, Kosh Agarwal
Publikováno v:
Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21e58c51c2399869f75adb1273aafd41
https://doi.org/10.1136/gutjnl-2022-basl.123
https://doi.org/10.1136/gutjnl-2022-basl.123
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 56(5)
Chronic hepatitis B remains a global health problem with an estimated 296 million people affected worldwide. Individuals are at risk of serious complications such as cirrhosis and hepatocellular carcinoma and accurately predicting these clinical endp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd6e3531cea05929c8c89c659456f239
https://pubmed.ncbi.nlm.nih.gov/35770458
https://pubmed.ncbi.nlm.nih.gov/35770458
Autor:
Milan J. Sonneveld, Shao-Ming Chiu, Jun Yong Park, Sylvia M. Brakenhoff, Apichat Kaewdech, Wai-Kay Seto, Yasuhito Tanaka, Ivana Carey, Margarita Papatheodoridi, Florian van Bömmel, Thomas Berg, Fabien Zoulim, Sang Hoon Ahn, George N. Dalekos, Nicole S. Erler, Christoph Höner zu Siederdissen, Heiner Wedemeyer, Markus Cornberg, Man-Fung Yuen, Kosh Agarwal, Andre Boonstra, Maria Buti, Teerha Piratvisuth, George Papatheodoridis, Chien-Hung Chen, Benjamin Maasoumy
Publikováno v:
Journal of Hepatology, 76(5), 1042-1050. Elsevier
Scientia
Scientia
Background & Aims: Nucleo(s)tide analogue (NUC) withdrawal may result in HBsAg clearance in a subset of patients. However, predictors of HBsAg loss after NUC withdrawal remain ill-defined. Methods: We studied predictors of HBsAg loss in a global coho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37c0d7cb4797db9a98e45e120981aaf6
https://pure.eur.nl/en/publications/eebbff8c-6a0f-448f-8386-4b40ac00d785
https://pure.eur.nl/en/publications/eebbff8c-6a0f-448f-8386-4b40ac00d785
